肌内注射肾上腺素改善心脏骤停结局:一项猪实验研究
该研究在36头38-42 kg猪中建立缺氧诱导心脏骤停3.5分钟模型,复苏时随机给予肌内注射肾上腺素0.125 mg/kg(0.125 mL/kg)或安慰剂(0.125 mL/kg生理盐水),两组均接受基础生命支持后高级生命支持(肌注后5分钟给予静脉肾上腺素)。主要终点ROSC率两组均为4/18(22%),差异无统计学意义(OR=1.00,95%CI 0.15-6.55,p=1.00)。冠状动脉灌注压和脑氧张力无差异,但干预组ROSC后30分钟(差值9.44 nmol/L,95%CI 3.42-15.5,p=0.009)和60分钟(差值15.9 nmol/L,95%CI 8.51-23.4,p=0.002)肾上腺素血浓度显著更高,ROSC后60分钟心输出量显著更高(差值2.58 L/min,95%CI 0.78-4.37,p=0.013)。
要点
- 在缺氧诱导猪心脏骤停模型中,肌内注射肾上腺素0.125 mg/kg(0.125 mL/kg)与安慰剂相比,ROSC率均为4/18(22%),OR=1.00(95%CI 0.15-6.55),p=1.00。
- 肌内注射肾上腺素并未改善冠状动脉灌注压(差值0.71 mmHg,95%CI -7.25至8.67,p=0.86)或脑氧张力(差值3.0 mmHg,95%CI -7.68至13.69,p=0.57)。
- 肌内注射肾上腺素组ROSC后30分钟肾上腺素血浓度差值9.44 nmol/L(95%CI 3.42-15.5,p=0.009),60分钟差值15.9 nmol/L(95%CI 8.51-23.4,p=0.002),均显著高于安慰剂组。
- 肌内注射肾上腺素组ROSC后60分钟心输出量显著更高,差值2.58 L/min(95%CI 0.78-4.37,p=0.013)。
- 作者结论:在静脉肾上腺素前5分钟早期肌内注射肾上腺素未提高ROSC率,但产生延长吸收,ROSC后30和60分钟肾上腺素水平更高。
适用人群与场景
- 38-42 kg猪,缺氧诱导心脏骤停3.5分钟模型。
处置流程与药物剂量
- 复苏时随机给予肌内注射肾上腺素0.125 mg/kg(0.125 mL/kg)或安慰剂0.125 mL/kg生理盐水。
- 两组均接受基础生命支持,随后高级生命支持包括在肌内注射后5分钟给予静脉肾上腺素。
- 达到ROSC的猪接受1小时重症监护。
研究设计与关键结果
- 研究类型:实验性猪研究;样本量36头(38-42 kg);随机分为肌内注射肾上腺素组(n=18)和安慰剂组(n=18)。
- 主要终点ROSC率:安慰剂组4/18(22%)vs 干预组4/18(22%),OR=1.00(95%CI 0.15-6.55),p=1.00。
- 冠状动脉灌注压差值0.71 mmHg(95%CI -7.25至8.67),p=0.86;脑氧张力差值3.0 mmHg(95%CI -7.68至13.69),p=0.57,均无显著差异。
- 肾上腺素血浓度:干预组ROSC后30分钟差值9.44 nmol/L(95%CI 3.42-15.5),p=0.009;60分钟差值15.9 nmol/L(95%CI 8.51-23.4),p=0.002,均显著高于安慰剂组。
- 心输出量:干预组ROSC后60分钟差值2.58 L/min(95%CI 0.78-4.37),p=0.013,显著高于安慰剂组。
证据类型、等级与局限
- 证据类型:实验性猪研究(动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:在静脉肾上腺素前5分钟早期肌内注射肾上腺素未提高ROSC率,但产生延长吸收,ROSC后30和60分钟肾上腺素水平更高。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To investigate early intramuscular adrenaline as an add-on treatment for cardiac arrest in a clinically relevant porcine model. We hypothesized that intramuscular adrenaline would improve return of spontaneous circulation (ROSC) compared to placebo.
METHODS: 36 pigs (38-42 kg) were subjected to hypoxia induced cardiac arrest for 3.5 min. During resuscitation, the pigs were randomized to either 0.125 mg/kg (0.125 mL/kg) intramuscular adrenaline or placebo 0.125 mL/kg normal saline. Both groups underwent basic life support followed by advanced life support including intravenous adrenaline 5 min after intramuscular adrenaline. Pigs achieving ROSC underwent one hour of intensive care. The primary outcome was ROSC.
RESULTS: The ROSC rate was 4/18 (22 %) in the placebo group and 4/18 (22 %) in the intervention group (OR = 1.00 95 %CI [0.15;6.55], p = 1.00). There was no difference in coronary perfusion pressure or cerebral oxygen tension (difference: 0.71 mmHg [95 %CI: -7.25; 8.67], p = 0.86 difference: 3.0 mmHg [95 %CI: -7.68; 13.69], p = 0.57). Adrenaline blood concentrations were significantly higher in the intervention group 30 min (difference: 9.44 nmol/L [95 %CI: 3.42; 15.5] p = 0.009) and 60 min after ROSC (difference: 15.9 nmol/L [95 %CI: 8.51; 23.4] p = 0.002). There was a significantly higher cardiac output in the intervention group 60 min after ROSC (difference: 2.58 L/min [95 %CI: 0.78; 4.37] p = 0.013).
CONCLUSION: Early intramuscular injection of adrenaline 5 min prior to intravenous adrenaline did not increase the ROSC rate but resulted in a prolonged absorption with higher adrenaline levels at 30 and 60 min after ROSC.
参考来源
- Kjærsgaard L, Nørholt C, Møller KF, et al. Intramuscular adrenaline to improve outcomes following cardiac arrest - An experimental porcine study. Resuscitation. 2025. PMID: 40783092. doi:10.1016/j.resuscitation.2025.110754
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。